Advertisement
Demo

FDA targets two clinics marketing unapproved stem cell therapies 

May 11, 2018 , CNN Health
The US Food and Drug Administration filed two federal complaints Wednesday seeking to permanently ban two clinics from marketing stem cell products without regulatory approval and accusing them of "significant deviations" from good manufacturing practice requirements. 


Read the full story...


Trending healthcare news keywords at this moment

brain million cancer disease drug students women sales care heart state healthcare people ebola risk vaccine fda generic medicare make gene lung kids study tip weight hospital mayo opioid medical finds patients top blood epipen